Subscribe to our Newsletter to increase your edge. Don’t worry about the news anymore, through our newsletter you’ll receive weekly access to what is happening. Join 120,000 other PE professionals today.
About Emcure Pharmaceuticals
Emcure Pharmaceuticals is driven by the purpose to develop, manufacture and market a broad range of pharmaceutical products globally. Their core strength and competitive advantage lies in our established presence in all major therapeutic areas including Gynaecology, cardiology, blood- related, oncology, respiratory, CNS & HIV among others. Emcure has launched 6 biosimilars in the Domestic Market & RoW markets & they are the domestic leader in three biologics. We are leading creation of India’s first indigenous mRNA vaccine to combat COVID- 19 which is currently under trials.
Source: Market Screener
Can’t stop reading? Read more
Fund Friday: Top fundraising news in private equity
Fund Friday: Top fundraising news in private equity BlackRock has paused fundraising for its...
JTC rebuffs £2bn Permira bid as shares surge to record high
JTC rebuffs £2bn Permira bid as shares surge to record high JTC Plc has rebuffed a preliminary...
Telefónica weighs bid for Vodafone Spain after Zegona’s €5bn acquisition
Telefónica weighs bid for Vodafone Spain after Zegona’s €5bn acquisition Telefónica is considering...